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Abstract
Objective—Dexamethasone (Dex) is a synthetic glucocorticoid that has pro-anabolic and anti-
catabolic effects in cartilage tissue engineering systems, though the mechanisms by which these
effects are mediated are not well understood. We tested the hypothesis that the addition of Dex to
chondrogenic medium would affect matrix production and aggrecanase activity of human and
bovine bone marrow stromal cells (BMSCs) cultured in self-assembling peptide and agarose
hydrogels.
Design—We cultured young bovine and adult human BMSCs in (RADA)4 self-assembling
peptide and agarose hydrogels in medium containing TGF-β1±Dex and analyzed extracellular
matrix composition, aggrecan cleavage products, and the effects of the glucocorticoid receptor
antagonist RU-486 on proteoglycan content, synthesis, and catabolic processing.
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Results—Dex improved proteoglycan synthesis and retention in agarose hydrogels seeded with
young bovine cells, but decreased proteoglycan accumulation in peptide scaffolds. These effects
were mediated by the glucocorticoid receptor. Adult human BMSCs showed minimal matrix
accumulation in agarose, but accumulated ~50% as much proteoglycan and collagen as young
bovine BMSCs in peptide hydrogels. Dex reduced aggrecanase activity in (RADA)4 and agarose
hydrogels, as measured by anti-NITEGE Western blotting, for both bovine and human BMSC-
seeded gels.
Conclusions—The effects of Dex on matrix production are dependent on cell source and
hydrogel identity. This is the first report of Dex reducing aggrecanase activity in a tissue
engineering culture system.
Keywords
Chondrogenesis; mesenchymal stem cells; degradative enzymes; articular cartilage; extracellular
matrix
Introduction
Tissue engineering using bone marrow-derived stromal cells (BMSCs) is an attractive
strategy for healing cartilage defects. BMSCs have been shown to differentiate to a cartilage
lineage in a variety of scaffolds and create cartilage-like extracellular matrix (ECM).1-4
These cells can be extracted without the need for further damage to the joint and expanded
for several passages without losing differentiation potential.5, 6 Additionally, BMSCs have
been found to synthesize ECM with higher dynamic stiffness, longer sulfated
glycosaminoglycan (sGAG) chains, and longer aggrecan core proteins than matrix
synthesized by chondrocytes, regardless of donor age.7 Despite progress in cartilage tissue
engineering, further optimization is needed to improve integration with native tissue,
mechanical function, and maintenance of the chondrocyte phenotype.8, 9
One strategy for improving our understanding of these complex systems is to investigate the
specific effects of chemical factors added to the cellular microenvironment. Dexamethasone
(Dex) is a synthetic glucocorticoid frequently added to culture medium for chondrogenesis
studies, motivated by research demonstrating pellet cultures of rabbit BMSCs stimulated
with TGF-β1 and Dex (TGF+Dex) grew larger than those cultured with TGF-β1 alone.2
Additional studies found that TGF+Dex increased aggrecan biosynthesis and gene
expression in bovine and human BMSCs over TGF-β1 alone.10, 11
Dex also has anti-catabolic properties. The aggrecanases ADAMTS-4/5 (a disintegrin and
metalloproteinase with thrombospondin motifs-4/5) are key destructive enzymes in human
osteoarthritis progression and are involved in cytokine-induced aggrecanolysis in cartilage
explants.12-14 ADAMTS-4/5–generated aggrecan fragments are also found in BMSC-seeded
hydrogels.3 Recently, Dex was found to reduce sGAG loss and rescue proteoglycan
synthesis in cartilage explants exposed to inflammatory cytokines.15 The mechanisms
through which Dex mediates pro-anabolic and anti-catabolic effects is not well understood,
though evidence that the glucocorticoid receptor mediates the increase in aggrecan mRNA
levels caused by Dex has been reported.16
We have used self-assembling peptide hydrogels for cartilage tissue engineering because
they support TGF-β1-induced chondrogenesis of BMSCs in vitro3 and have been
successfully used for studies of cartilage repair in animal studies.17, 18 Additionally, self-
assembling peptides have been used to deliver growth factors,18-21 which is important for
designing an optimal chondrogenic microenvironment as well as controlling sustained, local
delivery of growth factors. While scaffold-free, or pellet, cultures offer important culture
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systems for studying chondrogenesis, our objective was to investigate BMSC matrix
production and catabolism in hydrogel scaffolds motivated by the long-term translational
challenges of growth factor delivery and integration between neocartilage and adjacent
native cartilage. We tested the hypothesis that chondrogenesis of human and bovine BMSCs
in self-assembling peptide hydrogels, as well as subsequent matrix production and
aggrecanase activity, would be responsive to chondrogenic medium supplemented with Dex.
We compared the influence of Dex on chondrogenesis of young bovine BMSCs and adult
human BMSCs in (RADA)4 self-assembling peptide hydrogels and agarose hydrogels. By
analyzing accumulation of sGAG, DNA, and collagen, the effects of the glucocorticoid
receptor antagonist RU-486, and aggrecan cleavage products, we found that cell source and
scaffold environment changed the BMSC response to Dex, emphasizing the importance of
optimizing these variables for neocartilage generation. Dex reduced ADAMTS-4/5 activity
in (RADA)4 self-assembling peptide and agarose hydrogels for both cell types.
Methods
Bovine BMSC Isolation and Expansion
Bovine BMSCs were extracted from the femora and tibiae of four 1-2 week old calves
(Research 87, Marlborough, MA) as described previously.3 Briefly, marrow was isolated
aseptically, homogenized in phosphate-buffered saline (PBS), centrifuged, and the cell
fraction was plated on tissue culture plastic for 30 minutes to remove rapidly adhering cells.
The remaining cell population was plated into flasks at 1×106 mononuclear cells/cm2.
Remaining red blood cells were removed by a medium change two days after plating.
Colonies were expanded in low glucose Dulbecco’s modified Eagle’s medium (DMEM)
(Mediatech, Inc, Manassas, VA) with 10% fetal bovine serum (Invitrogen, Carlsbad, CA or
ThermoScientific, Logan, UT), penicillin streptomycin amphotericin (PSA) (Sigma-Aldrich,
St. Louis, MO), 4-(2-hydroxyethyl)-l-piperzaineethanesulfonic acid (HEPES) (Invitrogen),
and 1ng/mL basic fibroblast growth factor (bFGF) (R&D Systems, Minneapolis, MN) until
reaching 80% confluence as described previously.3 Cells were then removed by 0.05%
trypsin/0.53mM ethylenediaminetetraacetic acid (EDTA) (Invitrogen) and frozen for future
use (passage 0, P0). After thawing frozen P0 aliquots, cells were seeded at 6000 cells/cm2
and expanded two passages consisting of 3 days each in expansion medium with 5ng/mL
bFGF. BMSCs were then seeded into hydrogels for chondrogenesis studies.
Human BMSC Isolation and Expansion
Human BMSCs (hBMSCs) were isolated from intramedullary aspirate generated using a
Reamer Irrigator Aspirator device during surgical procedures performed at Brigham and
Women’s Hospital and Massachusetts General Hospital (Boston, MA).22 The three patients
whose cells were used in this study (two males, one female, ages 81, 51, and 37) granted
informed consent and surgical procedures were preapproved by the local Institutional
Review Board. The bulk aspirate was centrifuged, the red blood cell fraction lysed briefly in
a buffer of 155mM NH4Cl, 10mM KHCO3, and 0.1mM EDTA (pH 7.2), and BMSCs
isolated from the remaining nucleated cell fraction by differential adhesion to tissue culture
plastic as above. These donor cell populations have been confirmed to undergo
chondrogenic differentiation in pellet cultures in response to TGF-β1 and Dex.23 Frozen
aliquots of P1 or P2 cells were thawed and seeded at 1000 cells/cm2 in expansion medium
with 5ng/mL bFGF. Cultures received supplements of bFGF on day 4, passaged on day 6,
given more bFGF on day 9 or 10, and were seeded into hydrogels on day 12. One patient’s
cells required further expansion and were passaged on day 12, given more bFGF on day 14,
and cast on day 17.
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Hydrogel Encapsulation and Culture
Following BMSC expansion in monolayer, cells were encapsulated in one of two hydrogel
materials: (RADA)4 self-assembling peptide hydrogel (RAD, also known as PuraMatrix, a
gift from 3DM, Cambridge, MA) and low melting point agarose (Invitrogen, catalog number
15517-022). BMSCs were encapsulated in 0.5% (w/v) RAD or 2% (w/v) agarose at 107
cells/mL. These hydrogel concentrations were chosen to match previous studies.3, 4, 11, 24, 25
The cell/hydrogel mixture was cast as disks (~6mm diameter, 1.5mm thickness) into the
center of rings of acellular agarose pre-equilibrated in chondrogenic medium consisting of
high glucose DMEM, 1% ITS+1 (Sigma-Aldrich; insulin, transferrin, sodium selenite,
bovine serum albumin, and linoleic acid), proline (Sigma-Aldrich), ascorbate-2-phosphate
(Wako Chemicals, Richmond, VA), HEPES, PSA, non-essential amino acids (NEAA)
(Sigma-Aldrich), and sodium pyruvate (Invitrogen), as described previously.3 The cell-
seeded hydrogel disks were cultured in chondrogenic medium with 10ng/mL recombinant
human TGF-β1 (R&D Systems) with or without 100nM Dexamethasone (Sigma-Aldrich),
labeled TGF+Dex or TGF, respectively. Hydrogels were cultured for up to 21 days with
medium changes every 2-3 days. Some hydrogels were immediately cast into buffer
containing 50mM tris(hydroxymethyl)aminomethane (Tris) and 1mM CaCl2 to measure day
0 DNA levels.
Viability Staining
To assess viability of BMSCs for all culture conditions, hydrogels were viewed using a
Nikon Eclipse TE-300 fluorescence microscope at ~day 4 with 4μg/mL fluorescein diacetate
(live cells) and either 0.875μg/mL ethidium bromide or 35μg/mL propidium iodide (dead
cells).
Glucocorticoid Receptor Antagonist Culture
RU-486 (Mifepristone; Sigma-Aldrich), a glucocorticoid receptor antagonist with partial
agonist activity,26, 27 was added to the culture medium to determine whether observed
responses to Dex were mediated by the glucocorticoid receptor. A dose-response study
confirmed that 1μM RU-486 would not interfere with BMSC viability or sGAG synthesis.
This dose has been used previously.16 Bovine BMSCs were encapsulated in (RADA)4 or
agarose hydrogels as described above and cultured in medium with 10ng/mL TGF-β1 or
10ng/mL TGF-β1 with 100nM Dex with and without RU-486 for 21 days.
Hydrogel Biochemistry
For the final 24 hours of culture, hydrogels used for biochemical analysis were radiolabeled
with 5μCi/mL 35S-sulfate and 10 or 20μCi/mL 3H-thymidine (Perkin Elmer Inc, Waltham,
MA) to measure proteoglycan and DNA synthesis, respectively. Unincorporated radiolabel
was removed, hydrogels were weighed wet, lyophilized, weighed dry, and digested with
Proteinase-K (Roche Applied Science, Indianapolis, IN) as described previously.3 Digested
samples were assayed for sGAG content by 1.9-dimethylmethylene blue (DMMB) dye
binding,28 DNA content by Hoechst dye binding,29 and radiolabel incorporation by liquid
scintillation counting. Hydroxyproline content, as a measure of total collagen, was measured
by reaction with p-dimethylaminobenzaldehyde.30 sGAG released to the culture medium
was measured by DMMB.
Histology and Immunohistochemistry
Day 21 hydrogels from one experiment were fixed in 4% paraformaldehyde for 2 hours at
room temperature and overnight at 4°C. Osteochondral explants were collected from the
distal femurs of 1-2 week old bovine calves for collagen staining controls. Explants were
fixed in 4% paraformaldehyde, transferred to 70% ethanol, and demineralized. Gels and
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explants were then embedded in paraffin, sliced into sections, deparaffinized, and stained as
described previously in detail.3 Briefly, for immunohistochemistry, samples were stained for
type I or type II collagen; negative controls where incubated without primary antibodies.31
Additional sections were stained for sulfated proteoglycans using toluidine blue dye
solution.32 For detection of apoptotic cells, sections were stained with haematoxylin. Cells
with and without nuclear blebbing were counted using a Zeiss Axiophot microscope with
40x objective (Zeiss, Wetzlar, Germany). For quantification of nuclear blebbing,33 sections
from three different gels per experimental group were evaluated by counting cells in three
adjacent, distinct fields of vision in the center of each section. For each individual gel/
sample the percentage of apoptotic cells was calculated and the mean value for each
experimental group was given (n=3).
Aggrecan Extraction and Western blot Analysis
Additional hydrogels were cultured for 21 days, soaked in PBS with Complete Protease
Inhibitors (Roche) for ~2 hours, and frozen at -20°C until extraction. Hydrogels were rotated
in 4M guanidine hydrochloride with 100mM sodium acetate plus Protease Inhibitors for two
days at 4°C to extract proteoglycans. After centrifugation at 13,000 g for 30 mins, the
supernatant was removed and its sGAG content was measured by DMMB. Aggrecan extract
was then run through microcentrifuge tubes with a 10,000 MW cut-off (Millipore, Billerica,
MA). Retained protein was washed twice with buffer containing 0.05M Tris, 0.05M sodium
acetate, and 0.01M EDTA and resuspended in this buffer at a concentration of 1μg sGAG/
μL. The aggrecan was then deglycosylated using protease-free chondroitinase ABC (30mU/
100μg sGAG), keratanase II (0.5mU/100μg sGAG), and endo-β-galactosidase (0.5mU/
100μg sGAG) (Seikagaku Biobusiness Corporation, Tokyo, Japan). sGAG was loaded into a
4-12% Bis-Tris gel (Invitrogen) and run at 200V for 45 mins. Proteins were transferred to a
polyvinylidene fluoride membrane and probed with the anti-NITEGE monoclonal antibody
AGG-C134 (a gift from Dr. Carl Flannery, Pfizer) and the anti-G1 antibody G1-2 (a gift
from Dr. John Sandy, Rush University).35 Some membranes were stripped following anti-
NITEGE imaging and re-probed with anti-G1 antibody. To ensure the removal of the
NITEGE antibody following stripping, membranes were exposed to the secondary antibody
again and imaged to ensure no signal.
Statistical Analysis
Results are reported as mean±standard error of the mean. A linear mixed model of variance
with animal/patient as a random factor and medium condition and timepoint as fixed effects
was used to analyze data for experiments testing the effects of Dex on sGAG content, DNA
content, proteoglycan synthesis, DNA synthesis, sGAG retention, and hydroxyproline
content for bovine and human BMSCs. Data from the agarose and RAD scaffolds were
analyzed separately and not compared statistically. Data from experiments with RU-486
were analyzed using the same model with only the medium condition as a fixed effect.
Residual plots for all of the above comparisons were investigated and data were transformed
as necessary to ensure normality. Apoptotic cell data were analyzed using a general linear
model with medium condition as an independent variable. A Kolmogorov-Smirnov test was
used to ensure normality and data were transformed as necessary. Tukey post hoc tests with
p<0.05 were used to evaluate statistical significance for all pairwise comparisons. Statistical
tests were performed using Systat 12 software.
Results
Matrix and Cellular Content of Bovine BMSC-Seeded Hydrogels
sGAG content increased with time in both scaffolds seeded with bovine BMSCs, though
there was no statistical difference between days 14 and 21 in agarose hydrogels. By day 21,
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sGAG content of RAD hydrogels was nearly 150% of agarose hydrogels. Consistent with
previous literature,11 TGF+Dex significantly increased sGAG accumulation over TGF alone
in agarose hydrogels (Fig. 1A). In RAD, a decrease in sGAG accumulation was observed
with Dex compared to TGF alone on days 14 and 21. DNA content did not change
significantly between days 7 and 21 for either scaffold (Fig. 1B). In agarose, the addition of
Dex increased DNA content at all timepoints. Whereas little or no proliferation was
observed in agarose hydrogels, RAD hydrogels showed a 2.5 fold increase in DNA content
over day 0 levels by day 7. DNA content and sGAG normalized to DNA are also reported in
Supplementary figure S1.
Proteoglycan synthesis normalized to DNA content increased from day 7 to days 14 and 21
in RAD and remained elevated with TGF+Dex, while synthesis dropped at day 21 with TGF
alone (Fig. 1C). Proteoglycan synthesis showed a trend of decreasing over time in agarose.
TGF+Dex showed a significant increase compared to TGF alone for agarose at days 14 and
21, consistent with sGAG content. DNA synthesis rates normalized to DNA content were
not statistically different over time for the TGF+Dex condition in RAD, while the TGF
alone condition showed a significant decrease at day 21 (Fig. 1D). In agarose, DNA
synthesis decreased with time in both conditions. Dex supplementation significantly
increased DNA synthesis in agarose at day 7 and day 21.
Dex had a greater effect on sGAG retention in agarose than in RAD hydrogels (Fig. 1E). In
agarose, sGAG retention decreased from day 14 to day 21 and the addition of Dex
significantly increased retention at all timepoints. In contrast, sGAG retention was generally
higher in RAD than in agarose at all times with or without Dex. Dex increased sGAG
retention over TGF alone in RAD at day 7. Total sGAG produced and total sGAG
normalized to DNA are also reported in Supplementary figure S1.
Hydroxyproline content increased over time in both scaffolds (Fig. 1F), similar to the trends
in sGAG content. In RAD, addition of Dex decreased hydroxyproline content at all
timepoints compared to TGF alone. In agarose, there was no statistical difference between
TGF and TGF+Dex at any timepoint.
Histology and Immunohistochemistry
Toluidine blue staining of day 21 hydrogels (Fig. 2A) was consistent with the quantitative
sGAG content (Fig. 1A), with TGF+Dex and TGF gels showing similar levels of staining in
RAD and TGF+Dex agarose gels showing darker staining than TGF alone. Interestingly,
addition of Dex led to more diffuse staining throughout the agarose scaffold compared to the
largely pericellular staining for TGF alone.
To investigate the types of collagen present in day 21 hydrogels, immunohistochemistry was
performed. RAD hydrogels were positive for collagen type II staining, but agarose gels were
not (Fig. 2B). After analyzing multiple sections of RAD gels, a trend of more collagen type
II staining in TGF alone gels compared to TGF+Dex gels was seen in RAD, based on the
distribution of matrix areas that were stained positively. This was consistent with higher
levels of hydroxyproline in RAD gels with TGF alone compared to TGF+Dex (Fig. 1F).
Collagen type I staining was not seen in either agarose or RAD hydrogels (data not shown).
Day 21 hydrogels were also analyzed for nuclear blebbing as an indicator of apoptosis by
haematoxylin staining.33 Representative images showed little apoptosis in RAD gels with
either medium condition, while agarose gels showed much higher levels of blebbing (Fig.
2C). After reviewing multiple sections, the percentage of apoptotic cells was calculated for
each condition (Fig. 2D). Agarose hydrogels showed 20-30% of total cells being apoptotic,
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while RAD gels were near 2%. TGF+Dex showed a trend of less apoptosis than TGF alone
in agarose (19.0% vs 31.8%, p=0.186).
Glucocorticoid Receptor Antagonist Studies
RU-486 was added to the culture medium in ten-fold excess of Dex to determine whether
the previous responses were mediated by the glucocorticoid receptor. At day 21, TGF plus
RU-486 (TGF+RU) was not significantly different from the TGF alone condition in either
scaffold, as expected (Fig. 3A). Importantly, the addition of RU-486 to the TGF+Dex
condition significantly reduced sGAG levels such that there was no difference between TGF
+Dex+RU and TGF alone in agarose. In RAD, a decrease in sGAG content was observed
for TGF+Dex+RU compared to TGF+RU and TGF alone. DNA content was not
significantly different among media conditions in either scaffold (data not shown).
Addition of RU-486 to the TGF+Dex condition in agarose reduced proteoglycan synthesis
levels to that below TGF alone levels (Fig. 3B), consistent with the results of total sGAG
content analysis in Fig. 3A. In RAD, addition of RU-486 lowered the TGF+Dex production
of sGAG to that below the TGF alone level.
Bovine Aggrecan Western Blot
Western blots of aggrecan extracted from day 21 hydrogels were performed to analyze G1-
NITEGE neoepitope fragments generated by ADAMTS-4/5 cleavage as well as all
fragments containing a G1 domain. In agarose, both TGF and TGF+Dex showed NITEGE
fragments (Fig. 4A), though the staining was reduced in the TGF+Dex condition. In RAD,
NITEGE fragments were found in the TGF alone condition, but were dramatically reduced
for TGF+Dex. Addition of the RU-486 GR antagonist resulted in the reappearance of full-
intensity NITEGE bands when added to the TGF+Dex condition in both scaffolds. All
conditions in both scaffolds showed full-length aggrecan as a dominant species, with
NITEGE fragments also staining strongly in the agarose hydrogels (Fig. 4B). The ~140kDa
band is consistent with m-calpain activity,36, 37 although the activity of this enzyme was not
investigated specifically in this study. The bands between 40-50kDa are consistent with link
protein, which shares close homology to the aggrecan G1 domain.38, 39
Matrix Content and Aggrecan Western Blot for Human BMSC-Seeded Hydrogels
To investigate the applicability of these results to a more clinically relevant scenario, the
response of human BMSCs (hBMSCs) to Dex when cultured in RAD and agarose scaffolds
was also tested. hBMSCs produced minimal sGAG in agarose hydrogels (Fig. 5A), whereas
sGAG accumulation in RAD hydrogels seeded with hBMSCs was ~50% of that of young
bovine BMSCs in RAD gels. In agarose there was an increase in sGAG with Dex
supplementation at both timepoints, while in RAD Dex had no significant effect. In agarose
there was no significant increase in sGAG with time, whereas in RAD sGAG content
increased significantly from day 14 to 21. DNA content and sGAG normalized to DNA are
also reported in Supplementary figure S2.
Neither scaffold showed high levels of proliferation as measured by a fold change in DNA
compared to day 0 (Fig. 5B). In RAD, TGF+Dex showed more proliferation than TGF alone
at both timepoints. In agarose there was no significant effect of Dex. Neither scaffold
showed a significant change in DNA content from day 14 to 21.
Proteoglycan synthesis normalized to DNA content in RAD increased with time and was
higher in the TGF alone condition than TGF+Dex at both timepoints (Fig. 5C). Proteoglycan
synthesis in agarose increased with time and showed no significant effect of Dex.
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Hydroxyproline content in RAD hydrogels increased with TGF+Dex compared to TGF
alone at both timepoints (Fig. 5D). Hydroxyproline content increased with time in RAD for
both media conditions. Agarose showed identical statistical differences between conditions,
though the levels of hydroxyproline content were less than ~33% of those found in RAD.
sGAG retention levels were ~50% in RAD with a significant increase for TGF+Dex
compared to TGF alone (Fig. 5E). sGAG retention levels did not change significantly over
time in RAD. In agarose, sGAG retention decreased with time and was increased by the
addition of Dex. Total sGAG produced and total sGAG normalized to DNA are also
reported in Supplementary figure S2.
Consistent with Western blots performed on hydrogels seeded with bovine BMSCs,
aggrecan extracted from day 21 hBMSC-seeded RAD hydrogels showed NITEGE
fragments with TGF alone, but a dramatic decrease in NITEGE fragments with TGF+Dex
(Fig. 5F). Both conditions showed a strong full-length aggrecan band in the G1 blot.
Aggrecan from hBMSCs cultured in agarose gels was not analyzed by Western blotting due
to the limited quantity of sGAG produced.
Discussion
We hypothesized that Dex would improve matrix production and reduce ADAMTS-4/5
activity in agarose and RAD hydrogels seeded with adult human and young bovine BMSCs.
We tested this hypothesis by comparing sGAG, DNA, and hydroxyproline accumulation,
apoptosis, and ADAMTS-4/5-generated NITEGE fragments for self-assembling peptide and
agarose hydrogels cultured in TGF-β1±Dex. To our knowledge, this is the first study to
report that Dex affects ADAMTS-4/5 activity in a tissue engineering system. We found that
Dex reduced ADAMTS-4/5 activity across both hydrogel types and cell sources, but the
overall effects of Dex on chondrogenesis depended on the donor species/age and the type of
hydrogel. We have demonstrated chondrogenic differentiation through cartilage-like matrix
production, including aggrecan and type II collagen. Others have investigated the effects of
Dex on TGF-β-induced chondrogenesis at the gene expression level for both bovine and
human BMSCs and have found evidence of the pro-anabolic effects of Dex which are
consistent with our results.3, 11, 16, 40
For young bovine BMSCs in agarose, Dex caused a two-fold increase in sGAG content,
consistent with previous literature.11 This increase was due to the increase in proteoglycan
synthesis per cell caused by Dex. Although statistical comparisons were not made between
agarose and RAD hydrogel results, as this was the focus of our previous work,3 it is
interesting to note one additional finding. Bovine BMSCs proliferated to a greater extent in
RAD than agarose, which ultimately resulted in the accumulation of more total sGAG even
though sGAG per cell (as measured by sGAG normalized to DNA) was lower in RAD than
agarose for the TGF+Dex condition (Fig S1A). sGAG was better retained in bovine BMSC-
seeded agarose hydrogels with TGF+Dex compared to TGF alone. A trend of decreasing
apoptosis was found in the presence of Dex for young bovine BMSCs in agarose at day 21,
while RAD hydrogels with bovine BMSCs showed very little apoptosis in either condition.
RAD gels seeded with young bovine BMSCs had reduced sGAG and hydroxyproline
content in the presence of Dex compared to TGF-β1 alone, but the overall levels of these
matrix components were still higher than in agarose hydrogels in the presence of Dex at day
21. An increase in proteoglycan synthesis with Dex was observed on day 21; therefore it is
possible that longer culture duration with TGF+Dex could have resulted in increased sGAG
accumulation. The effects of Dex on sGAG accumulation and synthesis in both scaffolds
were mediated by the signaling of Dex through the glucocorticoid receptor, which correlates
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well with the ability of RU-486 to reverse Dex-induced aggrecan gene expression and type
II collagen production by human mesenchymal progenitor cells derived from bone.16
Hydrogels seeded with adult human BMSCs showed less matrix production overall
compared to young bovine-BMSC-seeded gels. In RAD hydrogels with hBMSCs, the
addition of Dex increased DNA and hydroxyproline content, but not sGAG content. We
were surprised to find very little evidence of chondrogenic differentiation by hBMSCs in
agarose. A previous study of hBMSCs in agarose showed evidence of proteoglycan and type
II collagen production at the protein level, but only one cell cluster was shown.25 hBMSCs
have been successfully cultured in other scaffold materials, though pellet culture remains
one of the most common culture methods for these cells.10, 16, 41-44
ADAMTS-4/5 activity, as measured by anti-NITEGE Western blotting, was decreased by
Dex in RAD and agarose hydrogels seeded with young bovine BMSCs and for RAD gels
seeded with adult human BMSCs. It is exciting that this finding was consistent across
scaffold type and cell species/age. A recent study has shown that Dex does not regulate
ADAMTS-4/5 activity at the gene expression level,15 but suggests the possibility that Dex
could be involved in regulating the activation of latent ADAMTS-4/5 enzymes. This is an
exciting research area that is the focus of ongoing studies. Use of the glucocorticoid receptor
antagonist RU-486 confirmed that the decrease in ADAMTS-4/5-generated NITEGE
fragments was mediated by the glucocorticoid receptor. This is an interesting finding that
should be investigated further.
There were several limitations to this study. First, apoptosis was only investigated at early
timepoints to ensure high viability, and at day 21 to compare to other histology samples.
Further study of cell death over the entire culture duration comparing across conditions
could aid in optimizing tissue engineering systems. Secondly, proteoglycan and DNA
synthesis data were normalized to DNA content (Fig 1, 3, 5), which underestimates the
synthesis levels in agarose, since the DNA levels include live and dead cells. Third,
hydroxyproline content reflects multiple collagen types and the type present in agarose gels
seeded with bovine BMSCs (Fig 1F) was not determined in this study. Since the matrix in
agarose was largely pericellular (Fig 2A) and the pericellular matrix (PCM) of primary
chondrocytes cultured for 21 days in agarose was found to be rich in type VI collagen,45 we
believe this is an abundant constituent of the PCM. Finally, our results encompassing young
bovine and adult human BMSCs do not allow us to conclude whether differences in
outcomes were associated with donor age or species. Both of these factors are important,
and given the conflicting evidence about the importance of donor age for BMSC therapies,
further studies are warranted.46 Recent work by Erickson et al. has shown that BMSCs from
young bovine tissue produce cell aggregates with higher sGAG and collagen content than
BMSCs from skeletally mature adult donors, bringing forth the hypothesis that the
difference in cell donor ages could be a contributing factor in this study.47 Despite the
limited number of human donors used in this study, we did find reproducible trends, which
allowed us to find the statistically significant differences between conditions presented here.
The differences we found between the cell types used here highlight the importance of
considering the effects of species and age differences when translating in vitro studies into a
clinical setting.
Several questions for future work remain, including how cell interactions with the scaffold
microenvironment affect differentiation, proliferation, matrix production and remodeling,
and cell death. This question is especially interesting given the lack of cartilage-like matrix
produced by human BMSCs in agarose. Variables that may affect the response of BMSCs to
Dex in different scaffolds include scaffold mechanical properties, scaffold interactions with
newly-synthesized matrix, and cell-mediated scaffold compaction. We previously reported
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that BMSCs maintain a rounded morphology in agarose throughout the culture duration,
whereas BMSCs in RAD spread and elongate to achieve a networked morphology with
extensive cell-cell contact early in culture.3 This is likely an important factor since cell-cell
contact is an essential aspect of chondrogenesis in limb bud formation.48
Dex does affect matrix production by BMSCs in agarose and RAD peptide scaffolds, but the
specific results depend on the cell source and the scaffold type. These findings highlight the
importance of choosing a scaffold, cell type, and growth factor combination carefully since
the interactions between these variables can change the outcome. Dex reduced
ADAMTS-4/5 activity in both types of hydrogels and both cell sources, suggesting an
exciting new avenue for investigating interactions between Dex and ADAMTS-4/5.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Extracellular matrix and cellular content in agarose and RAD hydrogels seeded with bovine
BMSCs and cultured in TGF or TGF+Dex medium. (A) sulfated glycosaminoglycan
(sGAG) content, (B) DNA content, (C) proteoglycan synthesis, (D) DNA synthesis, (E)
percent sGAG retained, (F) hydroxyproline content. Values are mean ± standard error of the
mean. n=13-16 (3-4 hydrogels × 4 animals). † versus TGF, * versus day 7, § versus day 14,
p<0.05
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Figure 2.
Representative staining of day 21 agarose and RAD hydrogels seeded with bovine BMSCs
and cultured with TGF or TGF+Dex medium. (A) Toluidine blue staining for proteoglycans,
(B) type II collagen immunohistochemistry, (C) haematoxylin staining for nuclear blebbing
(arrows indicate apoptotic cells), and (D) percentage of apoptotic cells, n=3, values are mean
± standard error of the mean. Controls performed on bovine osteochondral explants. Scale
bar is 30μm.
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Figure 3.
Effects of RU-486 on matrix production in agarose and RAD hydrogels seeded with bovine
BMSCs and cultured in TGF medium ± RU-486 and TGF+Dex ± RU-486 medium for 21
days. (A) sulfated glycosaminoglycan (sGAG) content and (B) proteoglycan synthesis.
Values are mean ± standard error of the mean. n=8 (4 hydrogels × 2 animals). Line indicates
significant difference between two conditions, p<0.05
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Figure 4.
Analysis of aggrecan cleavage products extracted from day 21 agarose and RAD hydrogels
seeded with bovine BMSCs and cultured in TGF medium (T) ± RU-486 (R) and TGF+Dex
(D) ± RU-486 medium. 10μg sGAG loaded per lane. (A) anti-NITEGE Western blot and (B)
anti-G1 Western blot. Arrows in (B) correspond to (a) full-length aggrecan, (b) potential m-
calpain cleavage fragment, (c) G1-NITEGE fragment, and (d) potential link protein. Anti-
NITEGE blot was stripped and re-probed with anti-G1 antibody to obtain image 4B.
Representative of two repeats for each experiment type.
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Figure 5.
Extracellular matrix and cellular content in agarose and RAD hydrogels seeded with human
BMSCs and cultured in TGF or TGF+Dex medium. (A) sulfated glycosaminoglycan
(sGAG) content, (B) DNA content, (C) proteoglycan synthesis, (D) hydroxyproline content,
(E) percent sGAG retained, (F) Western blot of aggrecan extracted from day 21 RAD gels
seeded with human BMSCS and cultured in TGF (T) and TGF+Dex (D) medium. Top blot
is anti-NITEGE, lower blot is anti-G1. 20μg sGAG loaded per lane. Values are mean ±
standard error of the mean. n=11-17 (3-6 hydrogels × 2-3 patients). † versus TGF, § versus
day 14, p<0.05
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